摘要
目的探讨莫沙比利治疗糖尿病胃轻瘫的疗效。方法54例2型糖尿病合并胃轻瘫患者随机分组,在控制血糖的基础上,治疗组予以莫沙比利治疗,对照组分别予以吗叮啉和胃复安,观察3组的临床症状(消化道症状)和不良反应。结果莫沙比利治疗组好转率明显高于对照组(P<0.05)。不良反应莫沙比利与吗叮啉组无统计学意义,莫沙比利与胃复安组有统计学意义。
Objective To evaluate the effects of Mosapfide in treatment for patients with Diabetic Gastmpathy. Methods 54 Diabetic Gastroparesis patients were randomly divided into 3 group and treated with Mosapride ,Motillum and metoclopramide,respectively . then the clinical symptoms and side effects were observed. Results The symptom relief rate of the Mosapfide＇s group was significantly higher than that of the control.The side effects of the Mosapride＇s group were less than that of Motilium and metoclopramlde groups and there was no significant difference between the metoclopramide and domperidone group.Conclussion Mosapride can be used as the first medicine for patients with Diabetic Gastropathy.
出处
《江西医药》
CAS
2005年第8期450-452,共3页
Jiangxi Medical Journal
